Advertisement

Pharmacy World & Science

, Volume 29, Issue 5, pp 526–533 | Cite as

Comparison of hospital pharmacy practice in France and Canada: can different practice perspectives complement each other?

  • Sonia Prot-LabartheEmail author
  • Jean-François Bussières
  • Françoise Brion
  • Olivier Bourdon
Research Article

Abstract

Objective

To compare hospital pharmacy practice in France and Canada by identifying similarities and differences in the two institution’s pharmacy activities, resources, drug dispensing processes and responsibilities.

Setting

Centre hospitalier universitaire Sainte-Justine (SJ), Montréal, Québec, Canada and Hôpital Robert Debré (RD), Paris, France, are two maternal-child teaching hospitals. They share a similar mission focused on patient care, teaching and research.

Method

The data were gathered from annual reports, department strategic plans and by direct observation.

Main outcome measure

The description and comparison of the legal environment, hospital demographics, pharmacy department data, drug dispensing processes and pharmacist activities in the two institutions.

Results

The Centre hospitalier universitaire Sainte-Justine and Hôpital Robert Debré are similar with respect to their mission and general demographics; number of beds, annual hospital expenditures, number of admissions, visits and childbirths. The respective pharmacy departments differ in allocated resources. The main operational differences concern compounding, quality control programs and clinical activities. The French department also manages medical devices, medical gases, blood derivatives and the sterilisation unit. These comparisons highlight the more patient-oriented Canadian hospital pharmacy practice against the more product-oriented French hospital practice Factors contributing to these differences include academic curriculum, the attention paid to the legal environment by professional bodies, staffing patterns and culture.

Conclusion

There are differences between the hospital pharmacy practice in the studied hospitals in Canada and France. Hospital pharmacy practice in France seems to be more product oriented, and the practice in Canada seems more patient oriented.

Keywords

Canada Cultural differences Education France Hospital pharmacy Hospital pharmacy practice Practice comparison 

References

  1. 1.
    LeBlanc JM, Dasta JF (2005) Scope of international hospital pharmacy practice. Ann Pharmacother 39(1):183–191PubMedGoogle Scholar
  2. 2.
    European Association of Hospital Pharmacists. EAHP Survey 2000. 2000 [cited 28th december 2005]; Available from: http://www.eahponline.org/asp/survey.asp?m=7&s=2
  3. 3.
    Thielke T, Nabeshina T, Hasegawa M (2002) Hospital pharmacy practice. Int Pharm J 16(1):1–40Google Scholar
  4. 4.
    Bussières J, Roy P, Lebel D, Binette M, Cambar J, Colombel C. (2002) Pratique pharmaceutique en France et au Québec: perspectives d’échanges? [Pharmaceutical practice in France and Quebec: profile of interships?]. J Pharm Clin 21:9–13Google Scholar
  5. 5.
    Bussieres J, Benabdessadok N, Roy H, Veyre M, Thiry-Alquier F (2004) Étude descriptive et comparative du circuit du médicament dans un établissement de santé français et un établissement québécois. A descriptive and comparative study of drug distribution systems in a French hospital and in a Quebec hospital. Le Pharmacien Hospitalier 39(157):67–75Google Scholar
  6. 6.
    McKerrow R, Johnson N, Hall K, Harding J, Bussières J, Lefebvre P, et al. 2001/2002 Annual Report: Hospital Pharmacy in Canada Survey. [cited 28th december 2005]; Available from: www.lillyhospitalsurvey.ca Google Scholar
  7. 7.
    Association des Pharmaciens des Établissements de Santé du Québec. Portail des échanges Québec-France en pharmacie [Quebec-France exchange in pharmacy]. 2005 [cited 21 decembre 2005]; Available from: http://www.apesquebec.org/echanges/index.htmhttp://www.apesquebec.org/echanges/index.htm
  8. 8.
    Réseau Mère-Enfant de la francophonie [Francophony mother-child network]. [cited 7 novembre 2003]; Available from: http://www.rme-francophonie.org/fr/
  9. 9.
    Arrêté du 31 mars 1999 relatif à la prescription, à la dispensation et à l’administration des médicaments soumis à la réglementation des substances vénéneuses dans les établissements de santé, les syndicats interhospitaliers et les établissements médico-sociaux disposant d’une pharmacie à usage intérieur mentionnés à l’article L. 595–1 du code de la santé publique [Bill 31st march 1999 related to Hospital Pharmacy drug use process (prescription, delivering and administration)]. In: Santé Publique; 1999Google Scholar
  10. 10.
    Décret n° 2000–1316 du 26 décembre 2000 relatif aux pharmacies à usage intérieur et modifiant le code de la santé publique—deuxième partie: Décrets en Conseil d’Etat [Bill n° 2000–1316 26th December 2000 related to hospital pharmacy and modifying public health policy code. Second Part]. In: Santé Publique; 2000Google Scholar
  11. 11.
    Loi réglementant certaines drogues et autres substances ch 19. 1996 [cited 27 september 2005]; Available from: http://lois.justice.gc.ca/fr/c-38.8/texte.html
  12. 12.
    Loi sur les aliments et drogues ch F-27. 1985 [cited 27 september 2005]; Available from: http://laws.justice.gc.ca/fr/f-27/texte.html
  13. 13.
    Loi sur les services de santé et services sociaux [Health services and social services Act]. [cited 6 february 2006]; Available from: http://www2.publicationsduquebec.gouv.qc.ca/home.php#
  14. 14.
    Loi sur l’assurance hospitalisation [Hospital Insurance Act]. [cited 6 february 2006]; Available from: http://www2.publicationsduquebec.gouv.qc.ca/home.php#
  15. 15.
    Loi sur la pharmacie [Pharmacy Act]. [cited 6 february 2006]; Available from: http://www2.publicationsduquebec.gouv.qc.ca/home.php#
  16. 16.
    Dekhtawala KN, Patel MS, Engle JP (1996) Pharmacy education and practice in France. Am J Health Syst Pharm 53(13):1600–1602PubMedGoogle Scholar
  17. 17.
    Cour des comptes. Rapport annuel au parlement sur la sécurité sociale septembre 2002 [Annual Report to Parlement about Healthcare coverage]. 2002 [cited 6 february 2006]; Available from: http://www.ccomptes.fr/Cour-des-comptes/publications/rapports/secu2002/introduction.htm
  18. 18.
    Institut canadien d’information sur la santé. Dépenses en médicaments au Canada [Drug Expenditures in Canada]. [cited 31st december 2005]; Available from: http://secure.cihi.ca/cihiweb/dispPage.jsp?cw_page=AR_80_F
  19. 19.
    Health Canada. Health Products and Food protection branch. Policy on manufacturing and compounding drug products in Canada POL-0051. DraftGoogle Scholar
  20. 20.
    Canales PL, Dorson PG, Crismon ML (2001) Outcomes assessment of clinical pharmacy services in a psychiatric inpatient setting. Am J Health Syst Pharm 58(14):1309–1316PubMedGoogle Scholar
  21. 21.
    Gattis WA, Hasselblad V, Whellan DJ, O’Connor CM (1999) Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 159(16):1939–1945PubMedCrossRefGoogle Scholar
  22. 22.
    Kane SL, Weber RJ, Dasta JF (2003) The impact of critical care pharmacists on enhancing patient outcomes. Intensive Care Med 29(5):691–698PubMedGoogle Scholar
  23. 23.
    Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M (1999) Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 19(7):860–869PubMedCrossRefGoogle Scholar
  24. 24.
    Bond CA, Raehl CL, Franke T (2002) Clinical pharmacy services, hospital pharmacy staffing, and medication errors in United States hospitals. Pharmacotherapy 22(2):134–147PubMedCrossRefGoogle Scholar
  25. 25.
    Folli HL, Poole RL, Benitz WE, Russo JC (1987) Medication error prevention by clinical pharmacists in two children’s hospitals. Pediatrics 79(5):718–722PubMedGoogle Scholar
  26. 26.
    Bjornson DC, Hiner WO Jr., Potyk RP, Nelson BA, Lombardo FA, Morton TA et al (1993) Effect of pharmacists on health care outcomes in hospitalized patients. Am J Hosp Pharm 50(9):1875–1884PubMedGoogle Scholar
  27. 27.
    McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA et al (1999) A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med 159(19):2306–2309PubMedCrossRefGoogle Scholar
  28. 28.
    Bond CA, Raehl CL, Franke T (2000) Clinical pharmacy services, pharmacy staffing, and the total cost of care in United States hospitals. Pharmacotherapy 20(6):609–621PubMedCrossRefGoogle Scholar
  29. 29.
    Krupicka MI, Bratton SL, Sonnenthal K, Goldstein B (2002) Impact of a pediatric clinical pharmacist in the pediatric intensive care unit. Crit Care Med 30(4):919–921PubMedCrossRefGoogle Scholar
  30. 30.
    Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL (2003) Evidence of the economic benefit of clinical pharmacy services: 1996–2000. Pharmacotherapy 23(1):113–132PubMedCrossRefGoogle Scholar
  31. 31.
    Prot-Labarthe S, Lavoie A, Bourdon O, Lebel D, Bussières J, Faye A et al (2007) Étude pilote sur la mise en place des soins pharmaceutiques dans le service de pédiatrie générale d’un hôpital français. Collaboration et comparaison franco-québécoise. Arch Pediatr accepted for publication doi:  10.1016/j.arcped.2006.12.003.

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Sonia Prot-Labarthe
    • 1
    Email author
  • Jean-François Bussières
    • 1
  • Françoise Brion
    • 2
  • Olivier Bourdon
    • 2
  1. 1.Unité de recherche en pratique pharmaceutique, Département de pharmacie, Centre hospitalier universitaire Sainte JustineUniversité de MontréalMontréalCanada
  2. 2.AP-HP, Hôpital Robert Debré, Département de pharmacie et centre pluridisciplinaire de dosage des médicamentsUniversité Paris 5 René DescartesParisFrance

Personalised recommendations